Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 126 participants.

Also called NCT01700322

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose basic science
Phase
Phase 4
Enrolled
  • 126 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01700322
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01700322. Randomized; single masking; primary purpose basic science. Start 2012-08 (registry gives no type); primary completion 2016-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study
Acronym
EST
Intervention (Procedure)
Coronary stenting
Intervention (Drug)
Ticagrelor
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Prasugrel
Lead sponsor
Johannes Gutenberg University Mainz (class: other)

Record details

Record id
cardio:ct-nct01700322
Content hash
8d9b2e3d05ad701d838a7f1197b9100379b216ec8ee4814310828c84c2cc9a30